Back to search

University of North Dakota

Staphylococcal Enterotoxin I Immunotherapy Combined With HLA-DQ8 Induces Tumoricidal Activity, With Low Superantigen Toxicity, Leading To Long-Term Survival And Tumor-Specific Memory Against Established B16-F10 Melanoma In Humanized HLA-DQ8 Transgenic Mice

Abstract

dc:description.abstract

Immunotherapies now stand at the forefront of cancer treatment as a versatile arsenal of cutting-edge tools wielded by medical professionals to combat and conquer a spectrum of formidable diseases. Most notably, immunotherapies such as immune checkpoint inhibitors, have revolutionized the field of oncology offering a promising alternative to conventional treatments like chemo and radiation therapy with significant improvements for patients in terms of quality of life and survival. Immunotherapies can be uniquely personalized to a patient's genetic and immune system profile leading to more effective treatments and durable long-lasting responses. Our research group has identified Staphylococcal enterotoxin I as a potent T cell activator that drives multifaceted antitumor responses but has not been incorporated into the arsenal due to the risk of HLA-associated toxicity. The following work aims to understand further and reduce that risk. HLA-DQ8 mice with established B16-F10 tumors receiving 25µg of SEI on days 6 and 9 post-tumor implant resulted in an astonishing 100% progression-free survival for greater than 400 days. However, SEI cancer immunotherapy was not successful in HLA-DR3 humanized transgenic or allogenic C57BL/6 mice. Furthermore, HLA-DQ8 mice rechallenged with 2.5x105 live B16-F10 cells experienced 100% survival for greater than 100 days post-implant. However, SEI immunotherapy was only limitedly effective against established Lewis lung carcinoma and did not provide cross-protection against rechallenge with either LLC or TC-1 tumor cell lines. The studies presented herein demonstrate that single superantigen SEI immunotherapy elicits antitumor responses against melanoma and supports further investigation into clinical applications of superantigen-based immunotherapies.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Biomedical Sciences

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Velaris, Nathan
Contributors dc:contributor
  • David S. Bradley

Identifiers

dc:identifier.*
Repository record dc:identifier
https://commons.und.edu/theses/5710

Chain of custody

source
Harvested from
University of North Dakota
Base URL
commons.und.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Velaris, Nathan. Staphylococcal Enterotoxin I Immunotherapy Combined With HLA-DQ8 Induces Tumoricidal Activity, With Low Superantigen Toxicity, Leading To Long-Term Survival And Tumor-Specific Memory Against Established B16-F10 Melanoma In Humanized HLA-DQ8 Transgenic Mice. Dissertation thesis, https://commons.und.edu/theses/5710